Vaxart (NASDAQ:VXRT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vaxart (VXRT) operate in?

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vaxart Stock (NASDAQ: VXRT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	3.50K / 3.10M
Day Range	- - -
52 Wk Range	0.52 - 1.54
Market Cap	$204.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.66%
Days to Cover	3.45

Recent News

Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside

Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus.

Vandana Singh

$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying

Avi Kapoor

Vaxart Stock Is Moving Higher After The Bell: What's Going On?

Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project NextGen award are expected to extend the company's cash runway into 2026.

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Vaxart Inc

Sector

Health Care

Industry

Biotechnology

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vaxart (VXRT) stock?

You can purchase shares of Vaxart (NASDAQ:VXRT) through any online brokerage.

View our list of the best stock brokerages

Who are Vaxart (VXRT) competitors?

Other companies in Vaxart’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA) and Galectin Therapeutics (NASDAQ:GALT).

What is the forecast, or price target, for Vaxart (VXRT) stock?

Vaxart has a consensus price target of $3.33.

What is the current price for Vaxart (VXRT)?

The stock price for Vaxart (NASDAQ: VXRT) is $0.9 last updated September 19, 2024 at 5:24 AM EDT.

Does Vaxart (VXRT) pay a dividend?

There are no upcoming dividends for Vaxart.

When is Vaxart (NASDAQ:VXRT) reporting earnings?

Vaxart’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Vaxart (VXRT) going to split?

There is no upcoming split for Vaxart.

What sector and industry does Vaxart (VXRT) operate in?

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now